HOTを伴うCOPD患者に対する長期HFNCの研究

基本情報

NCT ID: NCT03282019
ステータス: 完了
試験のフェーズ: 該当なし
試験タイプ: 介入
目標被験者数: 120
治験依頼者名: Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan

概要

This is a prospective, randomized parallel study for evaluation of the efficacy and safety of long-term nocturnal high-flow nasal cannula therapy (HFNC: with the myAIRVO2 as HFNC in this study) in stable COPD patients with the global initiative for chronic obstructive lung disease (GOLD) stage 2-4, PaCO2 \>= 45 Torr and hypercapnia who require home oxygen therapy (HOT) using COPD exacerbation (Moderate or Severe).

対象疾患

Chronic Obstructive Pulmonary Disease (COPD)

介入

High-flow nasal cannula therapy(DEVICE)

Home oxygen therapy (HOT)(DEVICE)

依頼者（Sponsor）

Translational Research Center For Medical Innovation, Kobe, Hyogo, Japan(OTHER)

Kobe City Medical Center General Hospital(UNKNOWN)

実施施設 (1)

神戸市立医療センター中央市民病院

Kobe, Hyōgo, Japan